These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

180 related articles for article (PubMed ID: 5740953)

  • 21. [Clinical work on a new drug combination used in liver diseases and its consequences].
    Naufal J
    Hospital (Rio J); 1969 Apr; 75(4):1469-82. PubMed ID: 5306437
    [No Abstract]   [Full Text] [Related]  

  • 22. [Alphamercaptopropionylglycine in chronic hepatopathies].
    Cacciari G; Malaguti P; Zincati GC
    Policlinico Med; 1972; 79(3):165-73. PubMed ID: 5051108
    [No Abstract]   [Full Text] [Related]  

  • 23. [Therapeutic efficiency of purified liver extract with an increased amount of vitamin B 12 in coenzymatic form in patients with liver diseases and rheumatoid arthritis].
    Guglielmi G; Garbagnati N; Iaschi P; Ciavarelli F; Ferrantelli D
    Clin Ter; 1969 Nov; 51(3):227-44. PubMed ID: 5407318
    [No Abstract]   [Full Text] [Related]  

  • 24. [Therapeutic effect of a preparation of total liver extract, cyanocobalamin and amino acids of the Krebs cycle, in acute and chronic liver diseases].
    Pignattari S; Sarti F; Toscano S; Dal Monte PR
    Minerva Med; 1972 Jul; 63(53):2861-72. PubMed ID: 5049878
    [No Abstract]   [Full Text] [Related]  

  • 25. [Considerations on the clinical use of a new association of drugs in the treatment of hepatopathies].
    Piva M; Ongari R
    Minerva Med; 1968 Jun; 59(46):2661-8. PubMed ID: 4233588
    [No Abstract]   [Full Text] [Related]  

  • 26. [Effects of parenteral administration of hepatotropic preparation with dynamotropic properties in patients with liver diseases].
    Rottini E; Scianaro L
    Clin Ter; 1969 Oct; 51(1):49-61. PubMed ID: 5364033
    [No Abstract]   [Full Text] [Related]  

  • 27. [Therapeutic effectiveness of B-vitamins and other drugs in chronic liver-parenchyma diseases?].
    Wildhirt E
    Munch Med Wochenschr; 1968 Oct; 110(40):2313-4. PubMed ID: 5761605
    [No Abstract]   [Full Text] [Related]  

  • 28. [Therapeutic effectiveness of B-vitamins and other drugs in chronic liver-parenchyma diseases?].
    Heinrich HC
    Munch Med Wochenschr; 1968 Oct; 110(40):2311-2. PubMed ID: 5761604
    [No Abstract]   [Full Text] [Related]  

  • 29. [Clinical test of the therapeutic effectiveness of hepatic opotherapy associated with high doses of nucleosides].
    Vercillo L; Mollica G; Florio G
    Minerva Med; 1972 Jun; 63(44):2478-85. PubMed ID: 5035396
    [No Abstract]   [Full Text] [Related]  

  • 30. [Clinico-therapeutic evaluation of a new drug combination with hepatotrophic effect].
    Piazza E; Sindoni G; Stornello C; Foti V
    Clin Ter; 1972 Jun; 61(5):399-417. PubMed ID: 4262149
    [No Abstract]   [Full Text] [Related]  

  • 31. [Hepatotropic and proteo-anabolic therapeutic effects of a total hepatic preparation with a constant titer of natural coenzymatic cobalamin].
    Guidetti E; Vacha R; Vacha G
    Clin Ter; 1969 May; 49(4):323-36. PubMed ID: 5795020
    [No Abstract]   [Full Text] [Related]  

  • 32. [Research on the hepatoprotective effect of 1-amino acids involved in the Krebs-Henseleit cycle associated with vitamins].
    Rossi L; Laghi V; Cavallaro A
    Minerva Med; 1968 Sep; 59(75):3919-30. PubMed ID: 4234452
    [No Abstract]   [Full Text] [Related]  

  • 33. [On the so-called hepatoprotective drugs. II. The so-called hepatoprotective drugs in the treatment of liver diseases].
    Mauro V
    Clin Ter; 1967 May; 41(3):265-86. PubMed ID: 4177978
    [No Abstract]   [Full Text] [Related]  

  • 34. [Hepa-listrocol in the therapy of chronic inflammatory liver diseases].
    Baum HH
    Landarzt; 1967 Apr; 43(11):530-3. PubMed ID: 5585071
    [No Abstract]   [Full Text] [Related]  

  • 35. [The use of different liver-protective substances in the course of antitubercular chemotherapy and their effectiveness in preventing and countering the appearance of metabolic and functional liver changes Clinico-statistical studies].
    Natale F; Perna G
    Arch Sci Med (Torino); 1979; 136(4):591-6. PubMed ID: 550759
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Controlled clinical trial of a new combination of phosphorylcholine, homocysteine-gamma-thiolactone and vitamin B 12 in the parenteral treatment of chronic hepatopathies].
    Bandini S; Monteforte S
    Clin Ter; 1974 Jun; 69(6):549-60. PubMed ID: 4845637
    [No Abstract]   [Full Text] [Related]  

  • 37. [Drug therapy of liver diseases with Hepatofalk].
    Hirsch W; Smerlings H
    Ther Ggw; 1976 Oct; 115(10):1719-54. PubMed ID: 136762
    [No Abstract]   [Full Text] [Related]  

  • 38. [On the action of a total liver extract in subacute and chronic hepatopathies].
    Bazzicalupo G; Coscelli C
    Minerva Med; 1968 Sep; 59(76):3977-82. PubMed ID: 5698739
    [No Abstract]   [Full Text] [Related]  

  • 39. [Critical assessment of the value of liver protection therapy].
    Rinetti M; Dei Cas L
    Minerva Gastroenterol; 1974; 20(3):90-6. PubMed ID: 4467044
    [No Abstract]   [Full Text] [Related]  

  • 40. [Biological evaluation of liver protective agents with special consideration of liver preparations. 9. Practical use of prepared methods for biological evaluation of commercial liver preparations].
    Dressel H; Richter J
    Pharmazie; 1969 Sep; 24(9):555-66. PubMed ID: 5368430
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.